Publications
P263
J. Antimicrob. Chemother. 2023, 78, 1378-1385.
A multifaceted strategy to optimize pharmacokinetics of antimicrobial therapy in patients with hospital-acquired infections-a monocentre quality improvement project.
https://doi.org/10.1093/jac/dkad094
P262
J. Antimicrob. Chemother. 2023, 78, 965-974.
Development and validation of a dosing nomogram for continuous infusion cloxacillin in infective endocarditis.
https://doi.org/10.1093/jac/dkad030
P261
Antibiotics 2023, 12,123.
Development of a Predictive Dosing Nomogram to Achieve PK/PD Targets of Amikacin Initial Dose in Critically Ill Patients: A Non-Parametric Approach.
https://doi.org/10.3390/antibiotics12010123
Autres publications scientifiques
PS28
J Antimicrob Chemother 2023, 78(12):2919-2925.
Dalbavancin plasma concentrations in 133 patients: a PK/PD observational study.
https://doi.org/10.1093/jac/dkad331
PS25
J Antimicrob Chemother 2023, dkad094.
A multifaceted strategy to optimize pharmacokinetics of antimicrobial therapy in patients with hospital-acquired infections—a monocentre quality improvement project.
https://doi.org/10.1093/jac/dkad094
PS24
J Antimicrob Chemother 2023, 8, 965-974.
Development and validation of a dosing nomogram for continuous infusion cloxacillin in infective endocarditis.
https://doi.org/10.1093/jac/dkad030
PS23
Antibiotics 2023, 12, 123.
Development of a Predictive Dosing Nomogram to Achieve PK/PD Targets of Amikacin Initial Dose in Critically Ill Patients: A Non-Parametric Approach.
https://doi.org/10.3390/antibiotics12010123
Brevets
Thèse